Aflac Inc. Continues to Deliver Strong Financial Performance in Q2 2026, Exceeding Expectations in Japan Sales

Aflac Incorporated has reported solid financial results for its second quarter of 2026, with net earnings per diluted share coming in at $1.63 and adjusted earnings per diluted share at $1.75.

The company's focused execution of its strategy has created long-term value for shareholders, according to Dan Amos, Chairman and CEO of Aflac Incorporated. In Japan, sales declined 5.6% to JPY 11 billion in the quarter due to a strong second-quarter comparison in 2025, but sales were up 7% for the first half of the year.

This reflected strong sales results of Tsumitasu and Anshin Palette medical insurance products, which delivered growth year-over-year. The company continues to promote the importance of third sector protection to new and younger customers with its innovative first sector savings-type life insurance product, Tsumitasu.

Aflac Japan premium persistency was 92.7% in the quarter, maintaining strong persistency while adding new premium through sales. This approach helps offset lapses and reissue as well as policies reaching paid-up status.

In the United States, Aflac U.S. saw a 2.6% increase in year-over-year sales in the second quarter, driven by momentum within its group business, especially group voluntary products and network dental and vision. Net earned premium increased 2.3% for the quarter with strong premium persistency of 79.4%, maintaining a solid pre-tax margin of 20.9%.

Aflac Incorporated continues to prioritize fulfilling promises made to policyholders while being responsive to shareholder needs, a primary responsibility as public insurance companies.